Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 140 financings and $6.8 Billion in aggregate as Lead, Joint, or Co-Manager in 2020
$18.0 Million
Uplisting To Nasdaq
// Sole Book-Running Manager
August 2021
$3.5 Million
Uplisting
// Sole Book-Running Manager
August 2021
$10.0 Million
Registered Direct Offering
// Sole Placement Agent
July 2021
$125.0 Million
Initial Public Offering
// Sole Book-Running Manager
July 2021
$8.3 Million
Registered Direct Offering
// Sole Placement Agent
July 2021
$22.5 Million
Registered Direct Offering
// Sole Placement Agent
July 2021
$5.0 Million
Private Placement
// Sole Placement Agent
July 2021
$125.0 Million
Initial Public Offering
// Sole Book-Running Manager
July 2021
$100.0 Million
Initial Public Offering
// Sole Book-Running Manager
July 2021
$50.0 Million
Initial Public Offering
// Underwriter & Financial Advisor
June 2021
$22.0 Million
Convertible Note
// Sole Placement Agent
June 2021
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.